MedPath

Adequate adjustment from insulin degludec to insulin pump therapy in patient with type 1 diabetes

Not Applicable
Recruiting
Conditions
type 1 diabetes
Registration Number
JPRN-UMIN000013136
Lead Sponsor
Department of Pediatrics Osaka City University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

patient who is under15 years old. patient whose HbA1c is over 7.5% patient with severe diabetes complication.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
AUC (area under the curve) for 8 hours from 24 hour after the last injection of insulin Degludec
Secondary Outcome Measures
NameTimeMethod
mean blood glucose value, Standard Deviation (SD), HbA1c
© Copyright 2025. All Rights Reserved by MedPath